Emmanuel CAEYMAEX
Pharma Expert, UCB
Emmanuel CAEYMAEX is Executive Vice President and Immunology Patient Value Unit Head at UCB. He leads the understanding of patient needs, the development and commercialization of solutions. Over the last 20 years Emmanuel has been instrumental in advancing UCB’s transformation into a global biopharma company focused on patients with severe diseases.